Joining us on this episode is Tom Neyarapally , co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is an AI-native biotech pioneering the use of generative chemogenomics and patient clinicogenomic data to virtually screen billions of potential drug candidates each day. TPM E47 highlights > Episode 47 links: Archetype Therapeutics Tom Neyarapally on LinkedIn “Exploring a “Patient-First” Path in Drug Discovery” , a Li...
Jun 24, 2025•43 min•Season 8Ep. 6
Stéphane Budel , founding partner at DeciBio, joins the Talking Precision Medicine Podcast to explore the future of the field. He unpacks how liquid biopsy, multi-omics, and AI are opening new doors for personalized care, why the diagnostics business model is holding innovation back, and what it will take to make complex tech usable for clinicians and patients alike. TPM E46 highlights > Episode 46 links: DeciBio Stephane Budel on LinkedIn DeciBio’s White Paper on AI in Drug Developm...
May 19, 2025•50 min•Season 8Ep. 5
Today’s guests are Anna Berkenblit , Chief Scientific and Medical Officer at the Pancreatic Cancer Action Network, and Sudheer Doss , Chief Business Officer at PanCAN. The Pancreatic Cancer Action Network is the leading organization dedicated to advancing progress against pancreatic cancer. It empowers patients and caregivers, drives early detection strategies, and revolutionizes the development of advanced and personalized treatments. TPM E45 highlights > Episode 45 links: Anna Berke...
Apr 22, 2025•46 min•Season 8Ep. 4
Today’s guest is Najat Khan , Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals. Recursion is widely recognized as one of the most visible—and so far, most successful—companies to emerge from the tech-bio movement. Many consider it the current industry leader. It has become an iconic name in the field of artificial intelligence for drug discovery. TPM E44 highlights > Episode 44 links: Najat Khan on LinkedIn Recursion...
Mar 28, 2025•39 min•Season 8Ep. 3
What a pleasure to welcome today’s guest, Ryan Fukushima , chief operating officer of TempusAI. Not only has Ryan helped build Tempus brick by brick from the earliest days, he is also CEO of Pathos AI, a biotech company using real world data and AI to develop true precision medicines. I don’t know how he juggles it all, but unless you’ve been hiding out these last few years, Tempus has become a household name in our industry, completing a highly successful IPO last year. But no need to take my w...
Feb 26, 2025•43 min•Season 8Ep. 2
Today my guest is Joydeep Goswami , newly appointed President and CEO of the storied biotechnology company LGC. Joydeep is also a strategy advisor to Genialis. Join us as we discuss his remarkable career and lessons learned at each step of the way. Come on in and have a listen. Episode 42 links: TPM E42 for highlights and links from this episode > Tempus Announces a Collaboration With Genialis Genialis’ Upcoming Events...
Jan 31, 2025•48 min•Season 8Ep. 1
This episode features a conversation with Shweta Maniar , who leads the Healthcare and Life Science effort at Google cloud. In just a few short years, artificial intelligence has gone from the stuff of hype and fairy tale to powerful and ubiquitous tools for all aspects of R&D and healthcare delivery. Google has been central to this sea change. I discuss with Shweta how her organization helps make these advanced capabilities available to the masses, and so much more. Join us! Episode 41 link...
Dec 18, 2024•37 min•Season 7Ep. 7
Our guest this episode is Charles Fisher , co-founder and currently Chief Scientific Officer of Unlearn.AI. Unlearn has been a leader in the advancement of Digital Twins as a tool to drastically improve the efficiency of clinical trials. Not only a visionary scientist and trailblazing entrepreneur, Charles is fearless with his hot takes. So sit back and enjoy this free wheeling conversation! Episode 40 links: TPM E40 for highlights and links from this episode > Potential of the X...
Nov 15, 2024•47 min•Season 7Ep. 6
What a genuine pleasure to sit with Thierry Bernard , CEO of Qiagen. As I told Thierry, Qiagen is a truly iconic brand for anyone who came up through molecular biology laboratories in the past 30 years. Their products were ubiquitous, and crucial, to the success of our research. In this conversation, Thierry talks about his global vision for precision medicine, and his mantra that we leave no patient behind. Episode 39 links: TPM E39 for highlights and links from this episode > Gen...
Oct 08, 2024•36 min•Season 7Ep. 5
What a pleasure to sit down with my long time colleague and friend, Art Krieg, to discuss his latest venture, Zola Therapeutics, and his adventures in the great outdoors. Art has launched and exited a number of innovative biotechs, each time delving deeper into mechanisms by which we can harness the immune system for therapeutic purposes. Join us as we discuss how — despite a well earned retirement — the siren song that led to Zola was strong enough to get Art back in the game. Episode 38 links:...
Aug 29, 2024•44 min•Season 7Ep. 4
In this episode I chat with Dr Sarah Hein, co-founder and CEO of March Biosciences, a Houston Based biotech developing cell therapies for T-cell malignancies. Sarah is an old friend and colleague from our days as trainees at Baylor College of Medicine, where we both circulated among those with ambitions of entrepreneurship. Sarah has definitely made good in that regard, as a serial entrepreneur deeply enmeshed in Houston’s growing life sciences and healthtech ecosystem. Episode 37 links: TPM...
Jul 22, 2024•39 min•Season 7Ep. 3
This episode features two guests, Jennifer Goldsack and Yashoda Sharma , of the Digital Medicine Society, or DiMe. We’re going to get into the nitty gritty of healthcare disparities in terms of access and outcomes, and how digital solutions are a big part of the overall solution. Episode 36 links: TPM E36 for highlights and links from this episode > Genialis’ Upcoming Events Genialis™ krasID...
May 24, 2024•44 min•Season 7Ep. 2
In this episode Genialis CEO Rafael Rosengarten sat down with Dr. Carolina Haefliger , head of translational medicine at Debiopharm, the privately held Swiss biopharma company focused on oncology drug development. They talked about de-risking promising new cancer drugs, and what it takes from the science to the team to the technologies. Episode 35 links: Visit TPM E35 for highlights and links from this episode > Learn more about Genialis™ krasID > New Genialis RNA Biomarker Accurat...
Apr 12, 2024•31 min•Season 7Ep. 1
Today we turn the mic around, as our guest Adam Stasio hosts an excellent podcast of his own. Adam’s day job, however, is running SciMed, a boutique life sciences software development company. Adam and Genialis CEO Rafael Rosengarten discuss the state of scientific software, the importance of agility and communication, and approaches to building a lasting company culture. Visit TPM E34 for highlights and links from this episode....
Dec 14, 2023•32 min•Season 6Ep. 6
Our guest today is Dr. Ashley Zehnder , co-founder and CEO of Fauna Bio. Fauna is a revolutionary young biotech company using comparative genomics of an array of non-traditional mammalian models to discover new therapeutic opportunities for people. What do ground squirrels have to do with treating battlefield trauma? Only one way to find out … Visit TPM E33 for highlights and links from this episode....
Oct 27, 2023•43 min•Season 6Ep. 4
In this episode, Genialis CEO Rafael Rosengarten sits down with Ajay Gopal, CEO and founder of Rx Studio. Rx Studio is a technology company using data science to tackle a major limitation to personalized medicine: drug dosing. Visit TPM E32 for highlights and links from this episode.
Aug 02, 2023•39 min•Season 6Ep. 4
In this episode, Genialis CEO Rafael Rosengarten speaks with BCG management consultant and healthcare innovation expert Amy MacDougall . They discuss emerging trends in healthcare, the role of AI, ethics and more, as well as BCG’s recently released 50 Most Innovative Companies List. Visit TPM E31 for highlights and links from this episode.
Jun 29, 2023•35 min•Season 6Ep. 3
This episode, Genialis’ thirtieth, is a bit different from the previous ones. CEO Rafael Rosengarten has not one, not two, but three guests, including the entire leadership team at Genialis . The gang discusses Genialis’ twin quests to build a great place to work and a business that makes a positive impact on the world. Visit TPM E30 for highlights and links from this episode....
May 31, 2023•51 min•Season 6Ep. 2
Our guest this episode is Dr. Susanna Harris , community lead at Vibe Bio. Susanna is a dedicated scientific communicator and an outspoken advocate for the mental health of PhD students and other science researchers. She has chronicled her journey from the academic lab bench to a venture incubator to a promising biotech company for a substantial social media following, and joins us today to dive into these topics and more. Visit TPM E29 for highlights and links from this episode....
Jan 26, 2023•45 min•Season 6Ep. 1
In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi , co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member. Visit TPM E28 for highlights and links from this episode....
Nov 30, 2022•46 min•Season 5Ep. 3
This episode features Jason Springs, co-founder and CEO of Endpoint Health, an ascendant precision therapeutics company. Jason is a serial entrepreneur, who with the co-founders of his previous company, is building Endpoint Health to bring together under one roof the data science, diagnostics and therapeutics necessary to achieve truly personalized care. Visit TPM E27 for highlights and links from this episode.
Jun 27, 2022•43 min•Season 5Ep. 2
In this episode 26, our host Rafael sits down with Harry Glorikian . Harry is an investor, author, podcaster and veteran of the healthtech industry. Harry walks us through his latest book, The Future You , and expounds on the ways that wearable devices, personal health data and artificial intelligence are changing healthcare as we know it. Visit TPM E26 for highlights and links from this episode....
Feb 28, 2022•34 min•Season 5Ep. 1
Earlier this summer, Rafael sat down with Peter Vranes and Hitesh Mehta , co-founders of Nutromics. Nutromics is developing a next generation lab-on-skin, a wearable device for continuous monitoring of health-critical biomarkers. Let’s get right to it. Visit TPM 25 for highlights and links from this episode.
Sep 05, 2021•32 min•Season 4Ep. 6
Our guest is Dr. Angeli Moeller , Head of Pharma International Informatics at Roche. Angeli and our host, Rafael, discuss data science in the big pharma leagues; geek out on data standards; and dive deep on patient data rights and barriers to care. Visit TPM E24 for highlights and links from this episode.
Jul 28, 2021•41 min•Season 4Ep. 5
Our guest for this episode of Talking Precision Medicine is Liang Schweizer from HiFiBiO Therapeutics - one of the most exciting young biotechs out there. They have built a discovery engine encompassing single cell, immune profiling and machine learning. Visit TPM E23 for highlights and links from this episode.
Feb 26, 2021•47 min•Season 4Ep. 1
Our guests for this episode of Talking Precision Medicine are Elissa Prichep and Cameron Fox of the World Economic Forum. Elissa and Cameron take us through the W.E.F’s precision medicine initiative, and explain how anticipating ethical tensions is key to envisioning policies for precision medicine across the globe. Visit TPM E22 for highlights and links from this episode....
Nov 19, 2020•50 min•Season 3Ep. 6
Reboot Rx is a different kind of biotech startup. Reboot’s mission is to find generic non-cancer drugs that can benefit cancer patients quickly and affordably. And as a not-for-profit, Reboot can stay focused on its mission. Given the number of paradigms Reboot hopes to shift at once, we decided to talk with all three co-founders: CEO Laura Kleiman , COO & CTO Pradeep Mangalath and CSO Catherine Del Vecchio Fitz . Each one provides perspective on their part of the puzzle. Visit TPM E21 for h...
Aug 31, 2020•51 min•Season 3Ep. 5
Today Rafael is joined by Dr. Sarma Velamuri , founder and CEO of Luminare. Luminare is a Houston-based digital health company dedicated to ending sepsis—the number 1 cause of death in US hospitals. In the conversation that follows, Dr. Velamuri explains how Luminare saves lives by streamlining hospital workflows, and by changing the behaviors of nurses and doctors. They’ve also made a giant leap into covid tracking, emerging as national leaders on this front. Visit TPM E20 for highlights and li...
Jun 11, 2020•47 min•Season 3Ep. 4
Today’s news is dominated by the corona virus and COVID-19 pandemic. Rightfully so. But today we’re bringing you a story of another class of viruses, called Phage. Phage are viruses that find and kill bacteria, and Felix is a Bay Area biotech harnessing the power of phage to fight the scourge of antibiotic resistant infections. So join our conversation with founder and CEO, Dr. Rob McBride, from wherever you have socially distanced yourself or locked down on quarantine, and learn about the virus...
Mar 17, 2020•36 min•Season 3Ep. 3
Today’s episode is a bit different — different in that we are rejoined by a previous guest — David Mittelman . David is CEO of Othram, the first genomics-based forensics company. The audience response to our first conversation was so overwhelming we wanted to have David back on. And the timing couldn’t be better. Since our last chat, David and Othram have been all over the news, and have launched a new database product. Visit TPM E18 for highlights and links from this episode....
Mar 04, 2020•33 min•Season 3Ep. 2
